Tower Research Capital LLC (Trc) X4 Pharmaceuticals, Inc Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,587 shares of XFOR stock, worth $7,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,587

Previous 10,776 44.65%

Holding current value

$7,325

Previous $7,000 71.43%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.28 - $0.82 $1,347 - $3,945	4,811 Added 44.65%	15,587 $12,000
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.86 $8,740 - $13,920	-16,187 Reduced 60.03%	10,776 $7,000
Q2 2024 Aug 13, 2024	BUY	$0.58 - $1.47 $6,237 - $15,808	10,754 Added 66.35%	26,963 $15,000
Q1 2024 May 15, 2024	BUY	$0.72 - $1.46 $2,787 - $5,651	3,871 Added 31.37%	16,209 $22,000
Q4 2023 Feb 13, 2024	BUY	$0.61 - $0.99 $1,257 - $2,040	2,061 Added 20.05%	12,338 $10,000
Q3 2023 Nov 14, 2023	BUY	$1.03 - $2.02 $4,589 - $9,001	4,456 Added 76.55%	10,277 $11,000
Q2 2023 Aug 14, 2023	BUY	$0.82 - $2.49 $4,109 - $12,477	5,011 Added 618.64%	5,821 $11,000
Q1 2023 May 09, 2023	SELL	$0.8 - $1.22 $7,533 - $11,488	-9,417 Reduced 92.08%	810 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.69 - $2.21 $7,056 - $22,601	10,227 New	10,227 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.91 $3,569 - $7,746	-4,056 Reduced 41.84%	5,639 $5,000
Q1 2022 May 12, 2022	BUY	$1.48 - $2.58 $14,348 - $25,013	9,695 New	9,695 $16,000
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $2,375 - $7,000	-1,250 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $54,273 - $77,277	-11,981 Reduced 90.55%	1,250 $7,000
Q2 2021 Aug 16, 2021	BUY	$6.49 - $9.56 $66,249 - $97,588	10,208 Added 337.68%	13,231 $86,000
Q1 2021 May 17, 2021	SELL	$6.63 - $10.28 $20,559 - $31,878	-3,101 Reduced 50.64%	3,023 $26,000
Q4 2020 Feb 16, 2021	SELL	$5.41 - $7.4 $62,020 - $84,833	-11,464 Reduced 65.18%	6,124 $39,000
Q3 2020 Nov 16, 2020	BUY	$6.09 - $9.15 $88,341 - $132,729	14,506 Added 470.67%	17,588 $119,000
Q2 2020 Aug 13, 2020	BUY	$7.98 - $10.44 $24,594 - $32,176	3,082 New	3,082 $29,000
Q3 2019 Nov 05, 2019	SELL	$11.06 - $15.75 $22,053 - $31,405	-1,994 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$12.57 - $21.67 $19,408 - $33,458	1,544 Added 343.11%	1,994 $30,000
Q1 2019 May 14, 2019	BUY	$15.19 - $22.98 $6,835 - $10,341	450 New	450 $8,000

Others Institutions Holding XFOR

# of Institutions

Shares Held

99.6M

Call Options Held

421K

Put Options Held

80.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $32.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) X4 Pharmaceuticals, Inc Transaction History